墨尔本代写论文

代写澳洲论文 医药学论文代写

代写澳洲论文  医药学论文代写

They further explained that the regulations are different in different regions according to the local legislation regulations and in United States (the largest market) there is no control on the price of sale of non-government drugs, but in Canada, the situation is entirely opposite and legislation have control on the prices of drugs from other countries as well. In the year 2010, the five big giants of the industry accounted almost 50% shares in total sales of the year with the following share in sales; Pfizer Inc. (12.2%), GlaxoSmithKline (11.0%), Johnson & Johnson (8.9%), Merck and Co., Inc. (7.5%), and Sanofi-Aventis U.S. LLC (7.0%). The situation leads the companies towards the alliance to work together in order to deal with threats of competition and research and development. Economists and business authors have defined merger and acquisition as “when companies deal with each others to buy, sell, and combine or to divide in different entities”. The major alliance in the form of merger and acquisition was the acquisition of Wyeth by the big name of Pfizer in pharmaceutical industry. In this essay we will analyze the strategic and financial aspect of the deal so that we can find out the reasons and answers of some important questions like why Pfizer acquired Wyeth and why Wyeth sell out its business to Pfizer etc. According to the official website of Pfizer October 15, 2009 Pfizer Inc. acquired Wyeth in a cash and stock. The deal was signed in $68 billion. The main points of the deal according to the terms and conditions was, each outstanding share of Wyeth common stock has been converted into the right to receive $33 in cash (without interest) and 0.985 of a share of Pfizer common stock according to the Editor of businesswire.com (2012).

代写澳洲论文  医药学论文代写

他们进一步解释说,根据当地的法律法规和美国法规在不同地区是不同的(最大的市场)在非药品销售价格没有控制,但在加拿大,情况完全相反的立法控制了其他国家的药品价格和。在2010年,该行业的五大巨头占据了近50%股在下面分享一年的销售额占总销售额;辉瑞,葛兰素史克公司(12.2%)(11%),约翰逊&约翰逊(8.9%),默克制药公司,公司(7.5%),和美国赛诺菲-安万特公司(7%)。形势使公司向联盟一起工作,为了应对竞争和研究与发展的威胁。经济学家和商业已经定义了并购作为“当公司应对他人购买,出售,并结合或分成不同的实体”。在并购大联盟是由辉瑞大牌惠氏制药行业中采集。在这篇文章中我们将分析该交易的战略和财务方面,我们可以找出原因并回答一些重要的问题像辉瑞收购惠氏的原因为什么惠氏公司出售其业务,辉瑞等根据辉瑞2009年10月15日辉瑞收购惠氏的官方网站以现金和股票。该协议是在68000000000美元的签约。根据本条款和条件是协议的要点,惠氏的普通股,每个优秀的份额已转化为有权获得33美元的现金(不计利息)和0.985股辉瑞公司普通股根据businesswire.com编辑(2012)。